Eris Lifesciences Limited (ERIS.NS)
INR 1401.3
(0.86%)
INR 1401.3
(0.86%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 28.82 INR | 2.56% |
| 2022 | 28.10 INR | -5.99% |
| 2021 | 29.89 INR | 14.26% |
| 2020 | 26.16 INR | 21.06% |
| 2019 | 21.61 INR | 2.17% |
| 2018 | 21.15 INR | -1.12% |
| 2017 | 21.39 INR | 19.16% |
| 2016 | 17.95 INR | 84.86% |
| 2015 | 9.71 INR | 49.61% |
| 2014 | 6.49 INR | 26.76% |
| 2013 | 5.12 INR | 21.04% |
| 2012 | 4.23 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 6.11 INR | 17.05% |
| 2024 Q2 | 6.73 INR | 10.15% |
| 2023 Q4 | 5.22 INR | -30.86% |
| 2023 Q1 | 6.98 INR | 45.11% |
| 2023 Q3 | 7.55 INR | -16.76% |
| 2023 FY | - INR | 2.56% |
| 2023 Q2 | 9.07 INR | 29.94% |
| 2022 Q3 | 7.49 INR | -15.37% |
| 2022 Q4 | 4.81 INR | -35.78% |
| 2022 Q1 | 6.96 INR | 17.77% |
| 2022 FY | - INR | -5.99% |
| 2022 Q2 | 8.85 INR | 27.16% |
| 2021 Q2 | 8.71 INR | 10.81% |
| 2021 Q4 | 5.91 INR | -20.24% |
| 2021 FY | - INR | 14.26% |
| 2021 Q1 | 7.86 INR | 56.26% |
| 2021 Q3 | 7.41 INR | -14.93% |
| 2020 Q3 | 6.65 INR | -16.14% |
| 2020 Q2 | 7.93 INR | 20.88% |
| 2020 Q1 | 6.56 INR | 58.45% |
| 2020 Q4 | 5.03 INR | -24.36% |
| 2020 FY | - INR | 21.06% |
| 2019 Q2 | 6.74 INR | 10.31% |
| 2019 FY | - INR | 2.17% |
| 2019 Q3 | 4.62 INR | -31.45% |
| 2019 Q4 | 4.14 INR | -10.39% |
| 2019 Q1 | 6.11 INR | 53.52% |
| 2018 Q1 | 5.18 INR | 27.59% |
| 2018 Q4 | 3.98 INR | -31.73% |
| 2018 FY | - INR | -1.12% |
| 2018 Q2 | 6.20 INR | 19.69% |
| 2018 Q3 | 5.83 INR | -5.97% |
| 2017 FY | - INR | 19.16% |
| 2017 Q4 | 4.06 INR | -25.23% |
| 2017 Q1 | 5.15 INR | 64.54% |
| 2017 Q2 | 6.71 INR | 30.29% |
| 2017 Q3 | 5.43 INR | -19.08% |
| 2016 Q1 | 4.56 INR | 0.0% |
| 2016 Q3 | 4.95 INR | -1.39% |
| 2016 FY | - INR | 84.86% |
| 2016 Q4 | 3.13 INR | -36.77% |
| 2016 Q2 | 5.02 INR | 10.09% |
| 2015 FY | - INR | 49.61% |
| 2014 FY | - INR | 26.76% |
| 2013 FY | - INR | 21.04% |
| 2012 FY | - INR | 0.0% |